Current Oncology Reports

, 18:12 | Cite as

Clinically Relevant Physical Benefits of Exercise Interventions in Breast Cancer Survivors

  • Amy A. Kirkham
  • Kelcey A. Bland
  • Sarah Sayyari
  • Kristin L. Campbell
  • Margot K. Davis
Breast Cancer (B Overmoyer, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Breast Cancer

Abstract

Evidence is currently limited for the effect of exercise on breast cancer clinical outcomes. However, several of the reported physical benefits of exercise, including peak oxygen consumption, functional capacity, muscle strength and lean mass, cardiovascular risk factors, and bone health, have established associations with disability, cardiovascular disease risk, morbidity, and mortality. This review will summarize the clinically relevant physical benefits of exercise interventions in breast cancer survivors and discuss recommendations for achieving these benefits. It will also describe potential differences in intervention delivery that may impact outcomes and, lastly, describe current physical activity guidelines for cancer survivors.

Keywords

Breast cancer Exercise Aerobic Resistance Flexibility Rehabilitation Exercise prescription Peak oxygen consumption Cardiorespiratory fitness Strength Lean mass Bone mineral density Cardiovascular disease 

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.••
    Schmitz KH, Courneya K, Matthews C, Demark-Wahnefried W, Galvão DA, Pinto BM, et al. American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc. 2010;42:1409–26. This is a consensus document published by experts in the field on the established benefits of exercise in cancer survivors. CrossRefPubMedGoogle Scholar
  2. 2.
    Fong DYT, Ho JWC, Hui BPH, Lee AM, Macfarlane DJ, Leung SSK, et al. Physical activity for cancer survivors: meta-analysis of randomised controlled trials. BMJ. 2012;344:e70.PubMedCentralCrossRefPubMedGoogle Scholar
  3. 3.
    McNeely ML, Campbell KL, Rowe BH, Klassen TP, Mackey JR, Courneya KS. Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis. CMAJ. 2006;175:34–41.PubMedCentralCrossRefPubMedGoogle Scholar
  4. 4.
    Lee J, Dodd MJ, Dibble SL, Abrams DI. Nausea at the end of adjuvant cancer treatment in relation to exercise during treatment in patients with breast cancer. Oncol Nurs Forum. 2008;35:830–5.CrossRefPubMedGoogle Scholar
  5. 5.•
    van Waart H, Stuiver MM, van Harten WH, Geleijn E, Kieffer JM, Buffart LM, et al. Effect of low-intensity physical activity and moderate- to high-intensity physical exercise during adjuvant chemotherapy on physical fitness, fatigue, and chemotherapy completion rates: results of the PACES randomized clinical trial. J Clin Oncol. 2015;33:1918–27. This is the only randomized control trial to compare supervised exercise to home-based exercise with a usual care control group. This study demonstrated several important benefits for both exercise groups. CrossRefPubMedGoogle Scholar
  6. 6.
    Mishra SI, Scherer RW, Geigle PM, Berlanstein DR, Topaloglu O, Gotay CC, et al. Exercise interventions on health-related quality of life for cancer survivors (review). Cochrane database of systematic reviews (Online). 2012;8.Google Scholar
  7. 7.
    Courneya KS, Segal RJ, Mackey JR, Gelmon K, Reid RD, Friedenreich CM, et al. Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. J Clin Oncol. 2007;25:4396–404.CrossRefPubMedGoogle Scholar
  8. 8.•
    Courneya KS, Segal RJ, McKenzie DC, Dong H, Gelmon K, Friedenreich CM, et al. Effects of exercise during adjuvant chemotherapy on breast cancer outcomes. Med Sci Sports Exerc. 2014;46:1744–51. This is the single study to report on the effect of a supervised exercise intervention on breast cancer outcomes. CrossRefPubMedGoogle Scholar
  9. 9.
    Jones LW, Eves ND, Haykowsky M, Freedland SJ, Mackey JR. Exercise intolerance in cancer and the role of exercise therapy to reverse dysfunction. Lancet Oncol. 2009;10:598–605.CrossRefPubMedGoogle Scholar
  10. 10.
    Levine BD. VO2max: what do we know, and what do we still need to know? J Physiol. 2008;586:25–34.PubMedCentralCrossRefPubMedGoogle Scholar
  11. 11.
    Hornsby WE, Douglas PS, West MJ, Kenjale AA, Lane AR, Schwitzer ER, et al. Safety and efficacy of aerobic training in operable breast cancer patients receiving neoadjuvant chemotherapy: a phase II randomized trial. Acta Oncol. 2014;53:65–74.CrossRefPubMedGoogle Scholar
  12. 12.•
    Jones LW, Courneya KS, Mackey JR, Muss HB, Pituskin EN, Scott JM, et al. Cardiopulmonary function and age-related decline across the breast cancer survivorship continuum. J Clin Oncol. 2012;30:2530–7. This is an excellent summary paper of the effects of breast cancer treatment on cardiorespiratory fitness and selected cardiovascular measures at different time points during treatment. PubMedCentralCrossRefPubMedGoogle Scholar
  13. 13.
    McGuire DK, Levine BD, Williamson JW, Snell PG. A 30-year follow-up of the Dallas Bed Rest and Training Study I. Effect of age on the cardiovascular response to exercise. Circulation. 2001;104:1358–66.CrossRefPubMedGoogle Scholar
  14. 14.
    Blair SN, Kohl HW, Paffenbarger RS, Clark DG, Cooper KH, Gibbons LW. Physical fitness and all-cause mortality. A prospective study of healthy men and women. JAMA. 1989;262:2395–401.CrossRefPubMedGoogle Scholar
  15. 15.
    Keteyian SJ, Brawner CA, Savage PD, Ehrman JK, Schairer J, Divine G, et al. Peak aerobic capacity predicts prognosis in patients with coronary heart disease. Am Heart J. 2008;156:292–300.CrossRefPubMedGoogle Scholar
  16. 16.
    Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood J. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med. 2002;346:793–801.CrossRefPubMedGoogle Scholar
  17. 17.
    Peel JB, Sui X, Adams SA, Hébert JR, Hardin JW, Blair SN. A prospective study of cardiorespiratory fitness and breast cancer mortality. Med Sci Sports Exerc. 2009;41:742–8.PubMedCentralCrossRefPubMedGoogle Scholar
  18. 18.
    Blair SN, Kohl HW, Barlow CE, Paffenbarger RS, Gibbons LW, Macera CA. Changes in physical fitness and all-cause mortality: a prospective study of healthy and unhealthy men. JAMA. 1995;273:1093–8.CrossRefPubMedGoogle Scholar
  19. 19.
    Schmidt K, Vogt L, Thiel C, Jäger E, Banzer W. Validity of the six-minute walk test in cancer patients. Int J Sports Med. 2013;34:631–6.CrossRefPubMedGoogle Scholar
  20. 20.
    Rasekaba T, Lee AL, Naughton MT, Williams TJ, Holland AE. The six-minute walk test: a useful metric for the cardiopulmonary patient. Int Med J. 2009;39:495–501.CrossRefGoogle Scholar
  21. 21.
    Fritz S, Lusardi M. White paper: “walking speed: the sixth vital sign.”. J Geriatr Phys Ther. 2009;32:2–5.CrossRefGoogle Scholar
  22. 22.
    Cesari M, Cerullo F, Zamboni V, Di Palma R, Scambia G, Balducci L, et al. Functional status and mortality in older women with gynecological cancer. J Gerontol A Biol Sci Med Sci. 2013;68:1129–33.CrossRefPubMedGoogle Scholar
  23. 23.
    Klepin HD, Geiger AM, Tooze JA, Newman AB, Colbert LH, Bauer DC, et al. Physical performance and subsequent disability and survival in older adults with malignancy: results from the Health, Aging and Body Composition Study. J Am Geriatr Soc. 2010;58:76–82.PubMedCentralCrossRefPubMedGoogle Scholar
  24. 24.
    Niederer D, Schmidt K, Vogt L, Egen J, Klingler J, Hübscher M, et al. Functional capacity and fear of falling in cancer patients undergoing chemotherapy. Gait Posture. 2014;39:865–9.CrossRefPubMedGoogle Scholar
  25. 25.
    Winters-Stone KM, Torgrimson B, Horak F, Eisner A, Nail L, Leo MC, et al. Identifying factors associated with falls in postmenopausal breast cancer survivors: a multi-disciplinary approach. Arch Phys Med Rehabil. 2011;92:646–52.PubMedCentralCrossRefPubMedGoogle Scholar
  26. 26.•
    Battaglini CL, Mills RC, Phillips BL, Lee JT, Story CE, Nascimento MG, et al. Twenty-five years of research on the effects of exercise training in breast cancer survivors: a systematic review of the literature. World J Clin Oncol. 2014;5:177–90. This is the most recent review summarizing the benefits of exercise training on numerous health outcomes. Google Scholar
  27. 27.
    Jones LW, Eves ND, Peppercorn J. Pre-exercise screening and prescription guidelines for cancer patients. Lancet Oncol. 2010;11:914–6.PubMedCentralCrossRefPubMedGoogle Scholar
  28. 28.
    Garber CE, Blissmer B, Deschenes MR, Franklin BA, Lamonte MJ, Lee I-M, et al. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults. Med Sci Sports Exerc. 2011;43:1334–59.CrossRefPubMedGoogle Scholar
  29. 29.
    Winters-Stone KM, Dobek J, Bennett JA, Nail LM, Leo MC, Schwartz A. The effect of resistance training on muscle strength and physical function in older, postmenopausal breast cancer survivors: a randomized controlled trial. J Cancer Surviv. 2011;6:189–99.PubMedCentralCrossRefPubMedGoogle Scholar
  30. 30.
    Litterini AJ, Fieler VK, Cavanaugh JT, Lee JQ. Differential effects of cardiovascular and resistance exercise on functional mobility in individuals with advanced cancer: a randomized trial. Arch Phys Med Rehabil. 2013;94:2329–35.CrossRefPubMedGoogle Scholar
  31. 31.
    Gagnon B, Murphy J, Eades M, Lemoignan J, Jelowicki M, Carney S, et al. A prospective evaluation of an interdisciplinary nutrition-rehabilitation program for patients with advanced cancer. Curr Oncol. 2013;20:310.PubMedCentralCrossRefPubMedGoogle Scholar
  32. 32.
    Rantanen T. Muscle strength, disability and mortality. Scand J Med Sci Sports. 2003;13:3–8.CrossRefPubMedGoogle Scholar
  33. 33.
    Newman AB, Kupelian V, Visser M, Simonsick EM, Goodpaster BH, Kritchevsky SB, et al. Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort. J Gerontol A Biol Sci Med Sci. 2006;61:72–7.CrossRefPubMedGoogle Scholar
  34. 34.
    Rantanen T, Guralnik JM, Foley D, Masaki K, Leveille S, Curb JD, et al. Midlife hand grip strength as a predictor of old age disability. JAMA. 1999;281:558–60.CrossRefPubMedGoogle Scholar
  35. 35.
    Sasaki H, Kasagi F, Yamada M, Fujita S. Grip strength predicts cause-specific mortality in middle-aged and elderly persons. Am J Med. 2007;120:337–42.CrossRefPubMedGoogle Scholar
  36. 36.
    Kirkham AA, Neil-Sztramko SE, Morgan J, Hodson S, Weller S, Mcrae T, et al. Health-related physical fitness assessment in a community-based cancer rehabilitation setting. Support Care Cancer. 2015;23:2525–33.CrossRefPubMedGoogle Scholar
  37. 37.
    Rietman JS, Dijkstra PU, Debreczeni R, Geertzen JH, Robinson DP, de Vries J. Impairments, disabilities and health related quality of life after treatment for breast cancer: a follow-up study 2.7 years after surgery. Disabil Rehabil. 2015;26:78–84.CrossRefGoogle Scholar
  38. 38.
    Cantarero-Villanueva I, Fernández-Lao C, Díaz-Rodríguez L, Fernández-de-las-Peñas C, Ruiz JR, Arroyo-Morales M. The handgrip strength test as a measure of function in breast cancer survivors. Am J Phys Med Rehabil. 2012;91:774–82.CrossRefPubMedGoogle Scholar
  39. 39.
    McCarthy EK, Horvat MA, Holtsberg PA, Wisenbaker JM. Repeated chair stands as a measure of lower limb strength in sexagenarian women. J Gerontol A Biol Sci Med Sci. 2004;59:1207–12.CrossRefPubMedGoogle Scholar
  40. 40.••
    Pescatello LS, Arena R, Riebe D, Thompson PD, editors. ACSM’s guidelines for exercise testing and prescription. 9th ed. Philadelphia: Wolters Kluwer Lippincott Williams & Wilkins; 2014. This book is the gold standard resource on exercise testing and prescription. Google Scholar
  41. 41.
    Goodpaster BH, Park SW, Harris TB, Kritchevsky SB, Nevitt M, Schwartz AV, et al. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci. 2006;61:1059–64.CrossRefPubMedGoogle Scholar
  42. 42.
    Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc. 2002;50:889–96.CrossRefPubMedGoogle Scholar
  43. 43.
    Kutynec CL, McCargar L, Barr SI, Hislop TG. Energy balance in women with breast cancer during adjuvant treatment. J Am Diet Assoc. 1999;99:1222–7.CrossRefPubMedGoogle Scholar
  44. 44.
    Harvie MN, Campbell IT, Baildam A, Howell A. Energy balance in early breast cancer patients receiving adjuvant chemotherapy. Breast Cancer Res Treat. 2004;83:201–10.CrossRefPubMedGoogle Scholar
  45. 45.
    Winters-Stone KM, Bennett JA, Nail L, Schwartz A. Strength, physical activity, and age predict fatigue in older breast cancer survivors. Oncol Nurs Forum. 2008;35:815–21.CrossRefPubMedGoogle Scholar
  46. 46.
    Winters-Stone KM, Nail L, Bennett JA, Schwartz A. Bone health and falls: fracture risk in breast cancer survivors with chemotherapy-induced amenorrhea. Oncol Nurs Forum. 2009;36:315–25.CrossRefPubMedGoogle Scholar
  47. 47.
    Irwin ML, editor. ACSM’s guide to exercise and cancer survivorship. Windsor: Human Kinetics; 2012.Google Scholar
  48. 48.
    Schmitz KH, Speck RM. Risks and benefits of physical activity among breast cancer survivors who have completed treatment. Women’s Health. 2010;6:221–38.CrossRefPubMedGoogle Scholar
  49. 49.
    Patnaik JL, Byers T, DiGuiseppi C, Dabelea D, Denberg TD. Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study. Breast Cancer Res. 2011;13:R64.PubMedCentralCrossRefPubMedGoogle Scholar
  50. 50.
    Hooning MJ, Botma A, Aleman BMP, Baaijens MHA, Bartelink H, Klijn JGM, et al. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. J Natl Cancer Inst. 2007;99:365–75.CrossRefPubMedGoogle Scholar
  51. 51.
    Riihimaki M, Thomsen H, Brandt A, Sundquist J, Hemminki K. Death causes in breast cancer patients. Ann Oncol. 2012;23:604–10.CrossRefPubMedGoogle Scholar
  52. 52.
    Jones LW, Haykowsky MJ, Swartz JJ, Douglas PS, Mackey JR. Early breast cancer therapy and cardiovascular injury. J Am Coll Cardiol. 2007;50:1435–41.CrossRefPubMedGoogle Scholar
  53. 53.
    World Heart Federation. Cardiovascular disease risk factors. World Heart Federation; 2013 pp. 1–4.Google Scholar
  54. 54.
    Yancik R, Wesley MN, Ries LA, Havlik RJ, Edwards BK, Yates JW. Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA. 2001;285:885–92.CrossRefPubMedGoogle Scholar
  55. 55.
    Yancik R, Havlik RJ, Wesley MN, Ries L, Long S, Rossi WK, et al. Cancer and comorbidity in older patients: a descriptive profile. Ann Epidemiol. 1996;6:399–412.CrossRefPubMedGoogle Scholar
  56. 56.
    Mouhayar E, Salahudeen A. Hypertension in cancer patients. Tex Heart Inst J. 2011;38:263–5.PubMedCentralPubMedGoogle Scholar
  57. 57.
    Stamler J, Rose G, Stamler R, Elliott P, Dyer A, Marmot M. INTERSALT study findings. Public health and medical care implications. Hypertension. 1989;14:570–7.CrossRefPubMedGoogle Scholar
  58. 58.
    Harris EER, Correa C, Hwang WT, Liao J, Litt HI, Ferrari VA, et al. Late cardiac mortality and morbidity in early-stage breast cancer patients after breast-conservation treatment. J Clin Oncol. 2006;24:4100–6.CrossRefPubMedGoogle Scholar
  59. 59.
    Mendis S, Puska P, Norrving B, editors. Global atlas on cardiovascular disease prevention and control. Geneva: World Health Organization; 2011.Google Scholar
  60. 60.
    Thompat W, Sukarayodhin S, Sornprom A, Sudjaroen Y, Laisupasin P. Comparison of serum lipid profiles between normal controls and breast cancer patients. J Lab Physicians. 2013;5:38.PubMedCentralCrossRefPubMedGoogle Scholar
  61. 61.
    Hasija K, Bagga HK. Alterations of serum cholesterol and serum lipoprotein in breast cancer of women. Indian J Clin Biochem. 2005;20:61–6.PubMedCentralCrossRefPubMedGoogle Scholar
  62. 62.
    Kökoğlu E, Karaarslan I, Karaarslan HM, Baloğlu H. Alterations of serum lipids and lipoproteins in breast cancer. Cancer Lett. 1994;82:175–8.CrossRefPubMedGoogle Scholar
  63. 63.
    Lopez-Saez J-B, Martinez-Rubio JA, Alvarez MM, Carrera CG, Dominguez Villar M, de Lomas Mier AG, et al. Metabolic profile of breast cancer in a population of women in southern Spain. Open Clin Cancer J. 2008;2:1–6.PubMedCentralCrossRefPubMedGoogle Scholar
  64. 64.
    Yadav NK, Poudel B, Thanpari C, Chandra KB. Assessment of biochemical profiles in premenopausal and postmenopausal women with breast cancer. Asian Pac J Cancer Prev. 2012;13:3385–8.CrossRefPubMedGoogle Scholar
  65. 65.
    Alexopoulos CG, Pournaras S, Vaslamatzis M, Avgerinos A, Raptis S. Changes in serum lipids and lipoproteins in cancer patients during chemotherapy. Cancer Chemother Pharmacol. 1992;30:412–6.CrossRefPubMedGoogle Scholar
  66. 66.
    Love RR, Wiebe DA, Newcomb PA, Cameron L, Leventhal H, Jordan VC, et al. Effects of tamoxifen on cardiovascular risk factors in postmenopausal women. Ann Intern Med. 1991;115:860–4.CrossRefPubMedGoogle Scholar
  67. 67.
    Irwin ML, McTiernan A, Baumgartner RN, Baumgartner KB, Bernstein L, Gilliland FD, et al. Changes in body fat and weight after a breast cancer diagnosis: influence of demographic, prognostic, and lifestyle factors. J Clin Oncol. 2005;23:774–82.PubMedCentralCrossRefPubMedGoogle Scholar
  68. 68.
    Goodwin PJ, Ennis M, Pritchard KI, McCready D, Koo J, Sidlofsky S, et al. Adjuvant treatment and onset of menopause predict weight gain after breast cancer diagnosis. J Clin Oncol. 1999;17:120.PubMedGoogle Scholar
  69. 69.•
    Ghose A, Kundu R, Toumeh A, Hornbeck C, Mohamed I. A review of obesity, insulin resistance, and the role of exercise in breast cancer patients. Nutr Cancer. 2015;67:197–202. This is a comprehensive review focusing on the interactions between breast cancer treatment, weight gain, and insurance resistance, with a discussion of the role of exercise. CrossRefPubMedGoogle Scholar
  70. 70.
    Wilson PWF, D’Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med. 2002;162:1867–72.CrossRefPubMedGoogle Scholar
  71. 71.
    Goodwin PJ, Ennis M, Bahl M, Fantus IG, Pritchard KI, Trudeau ME, et al. High insulin levels in newly diagnosed breast cancer patients reflect underlying insulin resistance and are associated with components of the insulin resistance syndrome. Breast Cancer Res Treat. 2008;114:517–25.CrossRefPubMedGoogle Scholar
  72. 72.
    Goodwin PJ, Ennis M, Pritchard KI, Trudeau ME, Koo J, Madarnas Y, et al. Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol. 2001;20:42–51.CrossRefGoogle Scholar
  73. 73.•
    Kirkham AA, Davis MK. Exercise prevention of cardiovascular disease in breast cancer survivors. J Oncol. 2015;Article ID 917606. This is the most recent review on the evidence for the role of exercise in preventing cardiovascular disease in breast cancer survivors. It summarizes the available animal research demonstrating the ability of aerobic exercise to attenuate direct effects of doxorubicin on the heart, as well as the effects of exercise on cardiovascular risk factors in breast cancer survivors. Google Scholar
  74. 74.
    Sturgeon KM, Ky B, Libonati JR, Schmitz KH. The effects of exercise on cardiovascular outcomes before, during, and after treatment for breast cancer. Breast Cancer Res Treat. 2014;143:219–26.PubMedCentralCrossRefPubMedGoogle Scholar
  75. 75.
    Collier SR, Kanaley JA, Carhart R, Frechette V, Tobin MM, Hall AK, et al. Effect of 4 weeks of aerobic or resistance exercise training on arterial stiffness, blood flow and blood pressure in pre- and stage-1 hypertensives. J Hum Hypertens. 2008;22:678–86.CrossRefPubMedGoogle Scholar
  76. 76.
    Schwartz AL. Exercise and weight gain in breast cancer patients receiving chemotherapy. Cancer Pract. 2000;8:231–7.CrossRefPubMedGoogle Scholar
  77. 77.
    Reeves MM, Terranova CO, Eakin EG, Demark-Wahnefried W. Weight loss intervention trials in women with breast cancer: a systematic review. Obes Rev. 2014;15:749–68.CrossRefPubMedGoogle Scholar
  78. 78.
    Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. New Engl J Med. 2001;344:1343–50.CrossRefPubMedGoogle Scholar
  79. 79.
    Demark-Wahnefried W, Case LD, Blackwell K, Marcom PK, Kraus W, Aziz N, et al. Results of a diet/exercise feasibility trial to prevent adverse body composition change in breast cancer patients on adjuvant chemotherapy. Clin Breast Cancer. 2008;8:70–9.CrossRefPubMedGoogle Scholar
  80. 80.
    Fairey AS, Courneya KS, Field CJ, Bell GJ, Jones LW, Mackey JR. Effects of exercise training on fasting insulin, insulin resistance, insulin-like growth factors, and insulin-like growth factor binding proteins in postmenopausal breast cancer survivors: a randomized controlled trial. Cancer Epidemiol Biomarkers Prev. 2003;12:721–7.PubMedGoogle Scholar
  81. 81.
    Guinan E, Hussey J, Broderick JM, Lithander FE, O’Donnell D, Kennedy MJ, et al. The effect of aerobic exercise on metabolic and inflammatory markers in breast cancer survivors—a pilot study. Support Care Cancer. 2013;21:1983–92.CrossRefPubMedGoogle Scholar
  82. 82.
    Irwin ML, Varma K, Alvarez-Reeves M, Cadmus L, Wiley A, Chung GG, et al. Randomized controlled trial of aerobic exercise on insulin and insulin-like growth factors in breast cancer survivors: the Yale Exercise and Survivorship Study. Cancer Epidemiol Biomarkers Prev. 2009;18:306–13.PubMedCentralCrossRefPubMedGoogle Scholar
  83. 83.
    Ligibel JA, Campbell N, Partridge A, Chen WY, Salinardi T, Chen H, et al. Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors. J Clin Oncol. 2008;26:907–12.CrossRefPubMedGoogle Scholar
  84. 84.
    Nuri R, Kordi MR, Moghaddasi M, Rahnama N, Damirchi A, Rahmani-Nia F, et al. Effect of combination exercise training on metabolic syndrome parameters in postmenopausal women with breast cancer. J Cancer Res Ther. 2012;8:238–42.CrossRefPubMedGoogle Scholar
  85. 85.
    Schmitz KH, Ahmed RL, Hannan PJ, Yee D. Safety and efficacy of weight training in recent breast cancer survivors to alter body composition, insulin, and insulin-like growth factor axis proteins. Cancer Epidemiol Biomarkers Prev. 2005;14:1672–80.CrossRefPubMedGoogle Scholar
  86. 86.
    Campbell KL, Van Patten CL, Neil SE, Kirkham AA, Gotay CC, Gelmon KA, et al. Feasibility of a lifestyle intervention on body weight and serum biomarkers in breast cancer survivors with overweight and obesity. J Acad Nutr Diet. 2012;112:559–67.CrossRefPubMedGoogle Scholar
  87. 87.
    Chen Z, Maricic M, Bassford TL, Pettinger M, Ritenbaugh C, Lopez AM, et al. Fracture risk among breast cancer survivors: results from the Women’s Health Initiative Observational Study. Arch Intern Med. 2005;165:552–8.CrossRefPubMedGoogle Scholar
  88. 88.
    Lester J, Dodwell D, McCloskey E, Coleman R. The causes and treatment of bone loss associated with carcinoma of the breast. Cancer Treat Rev. 2005;31:115–42.CrossRefPubMedGoogle Scholar
  89. 89.
    Schwartz AL, Winters-Stone K, Gallucci B. Exercise effects on bone mineral density in women with breast cancer receiving adjuvant chemotherapy. Oncol Nurs Forum. 2007;34:627–33.CrossRefPubMedGoogle Scholar
  90. 90.
    Winters-Stone KM, Dobek J, Nail L, Bennett JA, Leo MC, Naik A, et al. Strength training stops bone loss and builds muscle in postmenopausal breast cancer survivors: a randomized, controlled trial. Breast Cancer Res Treat. 2011;127:447–56.PubMedCentralCrossRefPubMedGoogle Scholar
  91. 91.
    Winters-Stone KM, Schwartz A, Nail LM. A review of exercise interventions to improve bone health in adult cancer survivors. J Cancer Surviv. 2010;4:187–201.CrossRefPubMedGoogle Scholar
  92. 92.
    Waltman NL, Twiss JJ, Ott CD, Gross GJ, Lindsey AM, Moore TE, et al. The effect of weight training on bone mineral density and bone turnover in postmenopausal breast cancer survivors with bone loss: a 24-month randomized controlled trial. Osteoporos Int. 2009;21:1361–9.CrossRefPubMedGoogle Scholar
  93. 93.
    Chia S. BCCA protocol summary for adjuvant therapy for breast cancer using doxorubicin and cyclophosphamide followed by pAclitaxel [Internet]. British Columbia Cancer Agency. 2000. http://www.bccancer.bc.ca/chemotherapy-protocols-site/Documents/Breast/BRAJACT_Protocol_1Dec2014.pdf. Accessed 10 Jul 2015.
  94. 94.
    Chang J. Chemotherapy dose reduction and delay in clinical practice: evaluating the risk to patient outcome in adjuvant chemotherapy for breast cancer. Eur J Cancer. 2000;36:11–4.CrossRefGoogle Scholar
  95. 95.
    Bluethmann SM, Vernon SW, Gabriel KP, Murphy CC, Bartholomew LK. Taking the next step: a systematic review and meta-analysis of physical activity and behavior change interventions in recent post-treatment breast cancer survivors. Breast Cancer Res Treat. 2015;149:331–42.PubMedCentralCrossRefPubMedGoogle Scholar
  96. 96.
    Yuen HK, Sword D. Home-based exercise to alleviate fatigue and improve functional capacity among breast cancer survivors. J Allied Health. 2007;36:e257–75.PubMedGoogle Scholar
  97. 97.
    Rock CL, Doyle C, Demark-Wahnefried W, Meyerhardt J, Courneya KS, Shwartz A, et al. Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin. 2012;62:275–6.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • Amy A. Kirkham
    • 1
  • Kelcey A. Bland
    • 1
  • Sarah Sayyari
    • 1
  • Kristin L. Campbell
    • 1
    • 2
  • Margot K. Davis
    • 3
  1. 1.Rehabilitation SciencesUniversity of British ColumbiaVancouverCanada
  2. 2.Department of Physical TherapyUniversity of British ColumbiaVancouverCanada
  3. 3.Division of CardiologyUniversity of British Columbia, Diamond Health Care CentreVancouverCanada

Personalised recommendations